NCT04011280View on ClinicalTrials.gov

Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

March 4, 2022

Study Completion Date

March 4, 2022

Conditions
Bipolar DisorderSchizophreniaSchizoaffective DisorderNicotine Dependence
Interventions
DRUG

Varenicline

The ten 30-minute sessions will target core processes in ACT such as acceptance and being present.

Trial Locations (1)

92093

Pacific Treatment & Research Center at UCSD, La Jolla

All Listed Sponsors
collaborator

Veterans Medical Research Foundation

OTHER

collaborator

University of California

OTHER

lead

University of California, San Diego

OTHER

NCT04011280 - Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness | Biotech Hunter | Biotech Hunter